Recto, Rudita .
HRN: 14-79-75 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/28/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/28/2023
08/04/2023
IV
4.5g
Q6hour
Empiric
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes